MSH2 and endometrial cancer: Molecular classification through well-established IHC staining for p53 and MMR proteins (MLH1, PMS2, MSH2, MSH6) in combination with targeted tumour sequencing (POLE hotspot analysis)43,44 should be carried out for all endometrial cancer pathology specimens regardless of histological type20 [IV, A].